Clinical trials
Epilepsy trials with no applicable phase and unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
93 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2007 | 2 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 4 |
| 2015 | 4 |
| 2016 | 6 |
| 2017 | 8 |
| 2018 | 6 |
| 2019 | 6 |
| 2020 | 11 |
| 2021 | 10 |
| 2022 | 7 |
| 2023 | 8 |
| 2024 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 93 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brain Sentinel | 3 |
| Central Hospital, Nancy, France | 3 |
| Assistance Publique Hopitaux De Marseille | 2 |
| Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2 |
| Empatica, Inc. | 2 |
| Epitel, Inc. | 2 |
| Great Ormond Street Hospital for Children NHS Foundation Trust | 2 |
| Hospices Civils de Lyon | 2 |
| Oslo University Hospital | 2 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Epilepsy | 93 |
| Seizures | 11 |
| Drug Resistant Epilepsy | 7 |
| Epilepsies, Partial | 5 |
| Alzheimer Disease | 3 |
| Anxiety Disorders | 2 |
| Epilepsy, Temporal Lobe | 2 |
| Neoplasms | 2 |
| Photosensitivity Disorders | 2 |
| Psychogenic Nonepileptic Seizures | 2 |
Trials
Showing 1 to 25 of 93. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.